Happily, AstraZeneca has developed a monoclonal antibody treatment “Evusheld”. This drug is used to prevent, rather than treat infections. It could imitate vaccination for immunocompromised people. 32 countries provide Evusheld as prophylaxis, but not UK. The UK’s Medicines and Healthcare products Regulatory Agency approved this drug in March 2022. But the health secretary declined to procure it, due to insufficient efficiency data in spite of many studies. For example, Israeli studies proved that immunocompromised people who received Evusheld were 92% less likely to be hospitalized or die from COVID.
This is why clinically vulnerable people have reported feeling forgotten by UK’s government. I think it’s terrible to leave immunocompromised people by themselves during this very likely winter COVID wave. In my opinion countries should invest in new drugs (after some reliable studies about it) and think about different groups of people struggling with this kind of difficult issues. UK government should really rethink its COVID strategy on a moral and public health basis.















































